What factors affect a sufficient dose of guaifenesin?

Guaifenesin is a drug used for cough productivity and can be used in the treatment of other health conditions such as asthma, DNA and fibromyalgia. A dose of Guaifenesin used to treat an individual may depend on many different factors. Such factors may include the age and weight of the individual, as well as the type of health condition used for treatment.

Adults tend to have a standard dose dose range, although this dose may change depending on whether the drug used is in immediate release or preparing the extension of release. For medicines with immediate release, the recommended dose of 200 to 400 milligrams (mg) is taken every 4 to 6 hours. Individuals with a heavier body weight or who have taken this medicine lately, may have to approach doses to 400 mg.

A normal adult dose that has an extended form of release of guaifenesin should take 600 mg to 1200 mg, twice daily. As with the formulation with immediate release ofLivacs or individuals who may have drug tolerance will often have to have a greater dose within this range. For individuals who use immediate or widespread versions of the release of this drug, the total dose of Guaifenesin should never exceed 2400 mg per day.

dosage for children can be done in one of two ways: by weight or age. By means of a weight -based method, the total dose of guaifenesin for this day is calculated to 0.35 mg per kilogram (kg) of body weight, corresponding to body weight 0.16 mg per pound (LB). This amount is divided into four to six smaller doses to be administered every four to six hours a day.

The

dose on the basis of age with this medicine uses doses of 50 mg to 100 mg, which have every four hours for children aged four to five years. Children six to 11 years usually last 100 mg to 200 mg every four to six hours. For the formulas of permanent releaseThis medicine, a dose of guaifenesin for children under five years of age is 300 mg every 12 hours and for children aged six to 11 years is a dose of 600 mg every 12 hours.

Experimental treatment of fibromyalgia known as the Guaifenesin protocol uses this medicine to alleviate some symptoms of this disease. It requires an initial dose of 300 mg, due to twice a day and the dosage increases over time. However, this specific use of Guaifenesin was not approved by any government regulatory agencies.